It will take a bigger trial with a comparison group that didn’t receive the treatment to know whether the stem cells truly slowed down the disease’s progression, though, said Angelo D’Alessandro, a professor at CU’s Anschutz Medical Campus. “The disease was overall stable,” he said.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045